{
    "title": "103_hr1926",
    "content": "The \"National Narcotics Leadership Act Amendments of 1993\" allows the Director to request funding for specific initiatives in line with the President's priorities for the National Drug Control Strategy. The National Narcotics Leadership Act of 1988 is amended to require the Director to report quarterly to Congress on the need for any funds reprogramming over $5,000,000 for drug control activities. Additionally, a new provision prohibits federal officers in the Office of National Drug Control Policy from participating in federal election campaign activities. The National Narcotics Leadership Act of 1988 is amended to require the Director to report quarterly to Congress on the need for funds reprogramming over $5,000,000 for drug control activities. Additionally, federal officers in the Office of National Drug Control Policy are prohibited from participating in federal election campaign activities. Section 1005(a) of the National Narcotics Leadership Act of 1988 is amended to include an evaluation of Federal drug control effectiveness in the National Drug Control Strategy, assessing reduction of drug use through various surveys and studies. The National Narcotics Leadership Act of 1988 is amended to include an evaluation of Federal drug control effectiveness in the National Drug Control Strategy, assessing reduction of drug use through surveys and studies, including estimates of drug prevalence, frequency of use, high-risk populations, drug availability, and productivity lost due to drug use. The National Narcotics Leadership Act of 1988 is amended to include an evaluation of Federal drug control effectiveness in the National Drug Control Strategy, assessing reduction of drug availability by measuring quantities of cocaine, heroin, and marijuana available in the US, amount of cocaine and heroin entering the US, hectares of poppy and coca cultivated and destroyed, metric tons of heroin and cocaine seized, cocaine processing labs destroyed, and changes in price and purity of heroin and cocaine. The evaluation of Federal drug control effectiveness in the National Drug Control Strategy includes assessing the reduction of drug availability by measuring quantities of cocaine, heroin, and marijuana available in the US, amount of cocaine and heroin entering the US, hectares of poppy and coca cultivated and destroyed, metric tons of heroin and cocaine seized, cocaine processing labs destroyed, changes in price and purity of heroin and cocaine, amount and type of controlled substances diverted from legitimate sources, and effectiveness of Federal technology programs in improving drug detection capabilities at US ports of entry. The assessment of the reduction of consequences of drug use includes estimating burdens on hospital emergency rooms, national healthcare costs related to drug use, and infections with HIV and other diseases due to drug use. The assessment includes national healthcare costs of drug use, drug-related crime, drugs' contribution to the underground economy, and the status of drug treatment capacity in the United States. The assessment includes determining the value of drugs sold in the United States and evaluating the status of drug treatment capacity, including availability of treatment slots, demand for treatment by specific groups, estimated number of drug users who could benefit from treatment, and the success of drug treatment. The Director assesses the success of drug treatment programs, including mechanisms to determine program quality, personnel qualifications, and patient admission processes. The Director evaluates drug treatment programs, assessing program quality, personnel qualifications, and patient admission processes. Additionally, the Director includes assessments of drug use measurement instruments and techniques in the National Drug Control Strategy. The Director evaluates drug treatment programs, personnel qualifications, and patient admission processes. Assessment of drug use measurement instruments and techniques is included in the National Drug Control Strategy, along with supply and demand reduction activities. Federal agencies are responsible for collecting drug-related information as required by the Director. The Director evaluates drug treatment programs, personnel qualifications, and patient admission processes. Federal agencies cooperate with the Director to provide drug-related information for the National Drug Control Strategy. The Director reports to the President and Congress on drug use and availability in the US, including the effectiveness of interdiction, treatment, prevention, law enforcement, and international programs. The Director evaluates drug treatment programs, personnel qualifications, and patient admission processes. Federal agencies cooperate to provide drug-related information for the National Drug Control Strategy. The Director reports to the President and Congress on drug use and availability in the US, including the effectiveness of interdiction, treatment, prevention, law enforcement, and international programs. The Director of the Office of National Drug Control Policy is added as a member of the National Security Council. Additionally, a Counter-Drug Technology Assessment Center is established. The National Narcotics Leadership Act of 1988 is amended to support the application of technology in drug treatment through interagency agreements or grants. Additionally, the Advanced Research Project Agency will provide assistance and support to the Office of National Drug Control. The National Narcotics Leadership Act of 1988 is amended to support technology in drug treatment through interagency agreements or grants. The Advanced Research Project Agency will provide assistance to the Office of National Drug Control Policy. The National Narcotics Leadership Act of 1988 is amended by repealing section 1008, redesignating section 1003A as section 1008, and moving it to follow section 1007. SEC. 7 amends the National Narcotics Leadership Act to allow the Director to pay for necessary expenses for strategy consultation. SEC. 8 authorizes appropriations as needed for fiscal year 1994. SEC. 9 changes the termination date of the Office of National Drug Control Policy to September 30, 1994. Section 1009 of the National Narcotics Leadership Act of 1988 is amended to change the termination date of the Office of National Drug Control Policy to September 30, 1994."
}